U

Urteste SA
WSE:URT

Watchlist Manager
Urteste SA
WSE:URT
Watchlist
Price: 92 PLN 4.07% Market Closed
Market Cap: 129.7m PLN
Have any thoughts about
Urteste SA?
Write Note

EV/OCF
Enterprise Value to OCF

-17.3
Current
-27.1
Median
5.9
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-17.3
=
Enterprise Value
111m PLN
/
Operating Cash Flow
-6.4m PLN
All Countries
Close
Market Cap EV/OCF
PL
Urteste SA
WSE:URT
129.7m PLN -17.3
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 691.7
US
Abbvie Inc
NYSE:ABBV
317.9B USD 22.4
US
Amgen Inc
NASDAQ:AMGN
141.7B USD 26.1
US
Gilead Sciences Inc
NASDAQ:GILD
117.1B USD 11.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
104.9B USD -115.3
US
Epizyme Inc
F:EPE
94.1B EUR -469.8
AU
CSL Ltd
ASX:CSL
135.7B AUD 34.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.4B USD 16.8
US
Seagen Inc
F:SGT
39.3B EUR -73.5
NL
argenx SE
XBRU:ARGX
36B EUR -132.6
 
PL
U
Urteste SA
WSE:URT
Average EV/OCF: 22.1
Negative Multiple: -17.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 691.7
US
Abbvie Inc
NYSE:ABBV
22.4
US
Amgen Inc
NASDAQ:AMGN
26.1
US
Gilead Sciences Inc
NASDAQ:GILD
11.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -115.3
US
E
Epizyme Inc
F:EPE
Negative Multiple: -469.8
AU
CSL Ltd
ASX:CSL
34.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -73.5
NL
argenx SE
XBRU:ARGX
Negative Multiple: -132.6

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More